Skip to main content
. 2017 Feb 14;37(4):1989–1997. doi: 10.3892/or.2017.5443

Figure 4.

Figure 4.

Correlation of ERCC1 expression in operable Xuanwei lung adenoma patient samples and the association of ERCC1 with patient survival. (A and B) Favorable overall survival and progression-free survival were associated with negative nuclear accumulation of ERCC1 (P<0.05). (C) The number of ERCC1 positive patients and IHC score of each case in the different stage groups. Increasingly more patients were detected as ERCC1-positive as the disease progressed (Chi-square test was applied for the analysis of ERCC1 positive rate. P<0.05). Stage IIIa patients had the highest IHC score. (Kruskal-Wallis test was applied for the analysis of IHC score of protein expression *P<0.05). (D) Typical patient samples of ERCC1 expression. Slides were stained with rabbit anti-ERCC1 antibody and visualized with goat anti-rabbit secondary antibody (magnification of ×400).